During the past decade, Allegheny Neurological Associates conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allegheny Neurological Associates" #1 sponsor was "Acorda Therapeutics" with 2 trials, followed by "Alexion" with 1 trials sponsored, "Beth Israel Deaconess Medical Center" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allegheny Neurological Associates" #1 collaborator was "Biogen" with 1 trials as a collaborator and "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Allegheny Neurological Associates" are "Multiple Sclerosis" (4 trials), "ALS" (1 trials), "Acute Brainstem/Cerebellar Syndrome" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Allegheny Neurological Associates" in a lesser frequency.

Most popular intervention types in "Allegheny Neurological Associates" are "Drug" (11 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Fampridine-SR" (2 trials), "Fenebrutinib" (1 trials), "Fingolimod" (1 trials) and "Ocrelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allegheny Neurological Associates" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Allegheny Neurological Associates". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Allegheny Neurological Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Allegheny Neurological Associates, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".